ESC CONGRESS 2019

31 August - 04 September 2019, Paris - France

Session Details

Insight into atrial physiology and pathology
Sun 01 Sep 10:05 - 10:55 Basic Science - Cardiac Diseases: Arrhythmias Moderated Posters, Abstract-based Programme Moderated ePoster 3 - Poster Area
Chairpersons: Natasja DE GROOT (Rotterdam, Netherlands (The)), Dobromir DOBREV (Essen, Germany)
Learning Objectives: Moderated Posters are on display from 08:30 to 11:30 on the plasma screen of the topic related Moderated Poster station. During the moderated poster session (10:05-10:55), from a large plasma screen, Presenters will summarise their research within 3 minutes and then address questions from the Chairpersons and Audience.

Access slides, videos, reports online via ESC Congress 365 Other resources

List of Presentations

Time
 
FP Nr
 
Title
 
Speakers
 
Related documents
10:05P1229Massive expansion of native human atrial cardiomyocytes through immortogenetics: generation of the hiAM cell linesNiels HARLAAR (Leiden, Netherlands (The))
10:05P1230Impact of regulated junctophilin-2 clustering at axial tubule junctions on atrial excitation-contraction coupling and therapeutic implicationsSoeren BRANDENBURG (Goettingen, Germany)
10:05P1231Loss of function in cytoskeletal genes associates with early onset atrial fibrillationOliver Bundgaard VAD (Copenhagen, Denmark)
10:05P1232A subpopulation of epicardium-derived cells are preprogrammed towards fibroblast differentiation in the atrial myocardiumNadine SUFFEE (Paris, France)
10:05P1233Differential effects of five risk variants for atrial fibrillation at the 4q25 region on L-type calcium current and transient inward currents in human atrial myocytesCarmen TARIFA (Barcelona, Spain)
10:05P1234Weight fluctuation demonstrates residual atrial arrhythmogenic substrate despite final weight loss in a chronic sheep model: implications for epicardial fat and fibrofatty infiltratesThomas Adam AGBAEDENG (Adelaide, Australia)
10:05P1235Acetylcholine-activated inward-rectifier potassium currents in atrial cardiomyocytes derived from induced pluripotent stem cells and atrial engineered heart muscle preparationsRobin SPRINGER (Goettingen, Germany)